Cargando…
Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis
Autores principales: | Fraga, Montserrat, Moradpour, Darius, Artru, Florent, Romailler, Elodie, Tschopp, Jonathan, Schneider, Antoine, Chtioui, Haithem, Neerman-Arbez, Marguerite, Casini, Alessandro, Alberio, Lorenzo, Sempoux, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Association for the Study of the Liver. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308036/ https://www.ncbi.nlm.nih.gov/pubmed/32585161 http://dx.doi.org/10.1016/j.jhep.2020.06.021 |
Ejemplares similares
-
Clinical Consequences and Molecular Bases of Low Fibrinogen Levels
por: Neerman-Arbez, Marguerite, et al.
Publicado: (2018) -
Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis
por: Artru, Florent, et al.
Publicado: (2020) -
Whole Blood Thromboelastometry by ROTEM and Thrombin Generation by Genesia According to the Genotype and Clinical Phenotype in Congenital Fibrinogen Disorders
por: Szanto, Timea, et al.
Publicado: (2021) -
Venous Thrombosis and Thrombocyte Activity in Zebrafish Models of Quantitative and Qualitative Fibrinogen Disorders
por: Fish, Richard J., et al.
Publicado: (2021) -
Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report
por: Fraga, Montserrat, et al.
Publicado: (2019)